Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARGeneric

ATROPINE (AUTOINJECTOR)

ATROPINE

Standard Dose
EQ 2MG SULFATE/0.7ML (EQ 2MG SULFATE/0.7ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ATROPINE (AUTOINJECTOR) is listed in Drugs@FDA under application 212319 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE Form and strength SOLUTION;INTRAMUSCULAR - EQ 2MG SULFATE/0.7ML (EQ 2MG SULFATE/0.7ML) Sponsor RAFA LABS LTD Submission history Latest submission status date: 2023-02-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATROPINE (AUTOINJECTOR) is listed in Drugs@FDA under application 212319 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE Form and strength SOLUTION;INTRAMUSCULAR - EQ 2MG SULFATE/0.7ML (EQ 2MG SULFATE/0.7ML) Sponsor RAFA LABS LTD Submission history Latest submission status date: 2023-02-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.